What is WVE's current stock price?

As of now, WVE is trading at $7.30, with a daily change of +3.48%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

WVE Stock Analysis & IQ Rating | Wave Life Sciences

WVE WVE Badge

Wave Life Sciences

$7.30

+$0.25 | +3.48%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$16.38

MKT CAP

$1.18B

52W Low

$5.28

VOL

$249.28K

P/E Ratio

N/A

AVG VOL

$3.14M

RSI

48.06

TREND

Sideways

WVE Stock IQ

Login to see Wave Life Sciences (WVE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

WVE Target Price

Login to display

Strengths

WVE Rewards

Upgraded on attractively valued

WVE Rewards

Earnings are forecast to grow

WVE Rewards

Trading below its fair value

WVE Rewards

Outperform the market

Chart

$7.59 (-3.82%)

$9.6 (-23.96%)

$6.95 (+5.04%)

$15.3 (-52.29%)

1year

6month

3month

1month

WVE Risk Level

WVE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low

LOW

HIGH

WVE Analysts Opinion

WVE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

WVE Analysts Opinion

WVE Analysts opinion is positive and also has improved from the past 3 months

WVE Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

56%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

WVE Street Sentiment

WVE Street Sentiment is bullish and have positive views on the near-term outlook

WVE Performance Sentiment

Sentiments overview associated with WVE events and the stock performance.

56%

44%

Positive

Negative

14 out of 25
events present

11 out of 25
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$7.05

Resistance
Price

$6.66

Current Price Range

$9.04

Show methods +

WVE Latest Analysis +

Jefferies Maintains Buy Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning. With significant upside potential Wave Life Sciences Ltd. (NASDAQ:WVE) secures a spot on our list of the best small-cap biotech stocks to buy according to analysts. On November 13 2025 Jefferies analyst Roger Song noted that Wave Life Sciences Ltd. (NASDAQ:WVE)s competitive positioning is improving with Korro Bios KRRO-110 reporting failure to produce protective levels [….]

Mon Nov 17, 2025

$7.15 | +0.99%

Potential

Rating

Wedbush Maintains Wave Life Sciences (WVE) Outperform Recommendation. Fintel reports that on November 11 2025 Wedbush maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Outperform recommendation. Analyst Price Forecast Suggests 178.18% Upside

Wed Nov 12, 2025

$6.96 | -4.20%

Potential

Rating

Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation. Fintel reports that on November 11 2025 Wells Fargo maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation. Analyst Price Forecast Suggests 178.18% Upside

Wed Nov 12, 2025

$6.96 | -4.20%

Rating

These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results. ) reported worse-than-expected third-quarter financial results on Monday.WAVE Life Sciences reported quarterly losses of 32 cents per share which missed the analyst consensus estimate of losses of 30 cents per share. The company reported quarterly sales of $7.608 million which missed the analyst consensus estimate of $11.130 million.“.In the third quarter we achieved key clinical objectives with WVE-007 for ob

Tue Nov 11, 2025

$7.26 | +2.98%

Earnings

Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2025 Earnings Call Transcript. Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2025 Earnings Call Transcript November 10 2025 Wave Life Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.32105 EPS expectations were $-0.3. Operator: Hello and welcome to Wave Life Sciences Ltd.’.s third quarter 2025 earnings call. We ask that you please hold all questions until the completion of [….]

Tue Nov 11, 2025

$7.26 | +2.98%

Earnings

Wave Life Sciences (WVE) Reports Q3 Loss Misses Revenue Estimates. Wave Life Sciences (WVE) delivered earnings and revenue surprises of -6.67% and -41.25% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Mon Nov 10, 2025

$7.05 | -10.31%

Earnings

Earnings Scheduled For November 10 2025. . CBAK Energy Tech (NASDAQ:CBAT) is likely to report quarterly loss at $0.04 per share on revenue of $39.27 million. . Townsquare Media (NYSE:) is estimated to report quarterly earnings at $0.03 per share on revenue of $107.98 million. . ARS Pharmaceuticals (NASDAQ:) is likely to report quarterly loss at $0.47 per share on revenue of $28.60 million. . Barrick Mining (NYSE:B) is projected to report quarterly earnings at $0.59 per share on revenue of $4.30

Mon Nov 10, 2025

$7.05 | -10.31%

Earnings

A Look Ahead: WAVE Life Sciencess Earnings Forecast. WAVE Life Sciences (NASDAQ:) will release its quarterly earnings report on Monday 2025-11-10. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate WAVE Life Sciences to report an The market awaits WAVE Life Sciences'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand that guidance can be a

Fri Nov 7, 2025

$7.86 | -0.25%

Earnings

Momentum

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025. Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosingIn preclinical models INHBE GalNAc-siRNA led to adipocyte shrinkage fewer pro-inflammatory macrophages less fibrosis and improved insul

Wed Nov 5, 2025

$8.04 | +0.25%

Activity

FAQ About WVE Stock Insights

What is WVE current stock price?

What are WVE stock strengths?

What is WVE Risk Level?

What is WVE market cap and volume?

What is WVE current Stock IQ?

Should I buy WVE stock right now?

Is WVE a Strong Buy right now?

What does a 'Strong Buy' rating mean for WVE?

What does a 'Strong Sell' rating mean for WVE?

What factors influence WVE's Stock IQ?

Explore our WVE Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored WVE Stock Strategies
Effective Risk Management

FIND US ON

Receive our WVE Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

WVE WVE Badge

Wave Life Sciences

Current Price

$7.30

+$0.25 | +3.48%

52W High

$16.38

MKT CAP

$1.18B

52W Low

$5.28

VOL

$249.28K

P/E Ratio

N/A

AVG VOL

$3.14M

RSI

48.06

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

WVE Rewards

Upgraded on attractively valued

WVE Rewards

Earnings are forecast to grow

WVE Rewards

Trading below its fair value

WVE Rewards

Outperform the market

WVE Stock IQ

Login to unlock Wave Life Sciences (WVE) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$7.59 (-3.82%)

$9.6 (-23.96%)

$6.95 (+5.04%)

$15.3 (-52.29%)

1year

6month

3month

1month

WVE Analysts Opinion

WVE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

WVE Analysts Opinion

WVE Analysts opinion is positive and also has improved from the past 3 months

WVE Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential.

56%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

100%

WVE Street Sentiment

WVE Street Sentiment is bullish and have positive views on the near-term outlook

WVE Risk Level

WVE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

Low

LOW

HIGH

WVE Performance Sentiment

Sentiments overview associated with WVE events and the stock performance.

56%

44%

Positive

Negative

14 out of 25
events present

11 out of 25
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$7.05

Resistance
Price

$6.66

Current Price Range

$9.04

Show methods +

WVE Latest Analysis

Jefferies Maintains Buy Rating on Wave Life Sciences (WVE) Amid Its Improving Competitive Positioning. With significant upside potential Wave Life Sciences Ltd. (NASDAQ:WVE) secures a spot on our list of the best small-cap biotech stocks to buy according to analysts. On November 13 2025 Jefferies analyst Roger Song noted that Wave Life Sciences Ltd. (NASDAQ:WVE)s competitive positioning is improving with Korro Bios KRRO-110 reporting failure to produce protective levels [….]

Mon Nov 17, 2025

$7.15 | +0.99%

Potential

Rating

Wedbush Maintains Wave Life Sciences (WVE) Outperform Recommendation. Fintel reports that on November 11 2025 Wedbush maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Outperform recommendation. Analyst Price Forecast Suggests 178.18% Upside

Wed Nov 12, 2025

$6.96 | -4.20%

Potential

Rating

Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation. Fintel reports that on November 11 2025 Wells Fargo maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation. Analyst Price Forecast Suggests 178.18% Upside

Wed Nov 12, 2025

$6.96 | -4.20%

Rating

These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results. ) reported worse-than-expected third-quarter financial results on Monday.WAVE Life Sciences reported quarterly losses of 32 cents per share which missed the analyst consensus estimate of losses of 30 cents per share. The company reported quarterly sales of $7.608 million which missed the analyst consensus estimate of $11.130 million.“.In the third quarter we achieved key clinical objectives with WVE-007 for ob

Tue Nov 11, 2025

$7.26 | +2.98%

Earnings

Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2025 Earnings Call Transcript. Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2025 Earnings Call Transcript November 10 2025 Wave Life Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.32105 EPS expectations were $-0.3. Operator: Hello and welcome to Wave Life Sciences Ltd.’.s third quarter 2025 earnings call. We ask that you please hold all questions until the completion of [….]

Tue Nov 11, 2025

$7.26 | +2.98%

Earnings

Wave Life Sciences (WVE) Reports Q3 Loss Misses Revenue Estimates. Wave Life Sciences (WVE) delivered earnings and revenue surprises of -6.67% and -41.25% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Mon Nov 10, 2025

$7.05 | -10.31%

Earnings

Earnings Scheduled For November 10 2025. . CBAK Energy Tech (NASDAQ:CBAT) is likely to report quarterly loss at $0.04 per share on revenue of $39.27 million. . Townsquare Media (NYSE:) is estimated to report quarterly earnings at $0.03 per share on revenue of $107.98 million. . ARS Pharmaceuticals (NASDAQ:) is likely to report quarterly loss at $0.47 per share on revenue of $28.60 million. . Barrick Mining (NYSE:B) is projected to report quarterly earnings at $0.59 per share on revenue of $4.30

Mon Nov 10, 2025

$7.05 | -10.31%

Earnings

A Look Ahead: WAVE Life Sciencess Earnings Forecast. WAVE Life Sciences (NASDAQ:) will release its quarterly earnings report on Monday 2025-11-10. Here'.s a brief overview for investors ahead of the announcement.Analysts anticipate WAVE Life Sciences to report an The market awaits WAVE Life Sciences'.s announcement with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.It'.s important for new investors to understand that guidance can be a

Fri Nov 7, 2025

$7.86 | -0.25%

Earnings

Momentum

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025. Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosingIn preclinical models INHBE GalNAc-siRNA led to adipocyte shrinkage fewer pro-inflammatory macrophages less fibrosis and improved insul

Wed Nov 5, 2025

$8.04 | +0.25%

Activity

Discover WVE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of WVE. We're here to help you make informed investment decisions today.

FIND US ON

Receive our WVE Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

WVE Stock trends

WVE Stock performance

WVE Stock analysis

WVE investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing WVE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing WVE

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

WVE Stock Analysis & IQ Rating | Wave Life Sciences

WVE Stock IQ

WVE Target Price

WVE Risk Level

WVE Analysts Opinion

WVE Street Sentiment

WVE Performance Sentiment

Technical Price Levels

Explore our WVE Stock insights

Receive our WVE Daily Alerts

WVE Stock IQ

WVE Street Sentiment

WVE Risk Level

Technical Price Levels

Discover WVE Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of WVE. We're here to help you make informed investment decisions today.

Receive our WVE Daily Alerts

WVE Runner Alarm